{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:34:10Z","timestamp":1786998850026,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Liver transplantation is the treatment of choice for end-stage liver disease. Livers obtained from donation after circulatory death (DCD) are subjected to significant ischemia-reperfusion injury (IRI) and require novel organ preservation measures. The overall objective of our study was to evaluate the protective effect of treprostinil against IRI in DCD livers by using normothermic machine perfusion (NMP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Circulatory arrest was induced in male Sprague-Dawley rats, and the organs were subjected to 30\u2009min of warm ischemic time in situ, mimicking the process of DCD liver transplantation. Livers were procured and cold preserved until mounted to ex vivo NMP. DCD livers underwent NMP with or without 20\u2009ng\/mL treprostinil in perfusate for 4\u2009h. Perfusate and bile samples were collected to assess hepatic and biliary viability parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Treprostinil effectively minimized IRI in rat DCD livers. Levels of alanine aminotransferase and aspartate aminotransferase were significantly higher in DCD-control, whereas treprostinil supplementation during NMP reduced the levels by 50% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001) and 30% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.036) of DCD-control, respectively. The portal venous pressure was higher in DCD-control (10.4\u2005\u00b1\u20054.3\u2009mm Hg), and significantly lowered in DCD-treprostinil group (4.2\u2005\u00b1\u20051.0\u2009mm Hg;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001). Livers perfused with treprostinil produced 1.5-fold (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.01) higher bile volume, compared with DCD-control. The bile pH and lactate dehydrogenase showed improvement in the DCD-treprostinil group compared with the DCD-control and were comparable to naive livers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Treprostinil supplementation during NMP of DCD livers reduced IRI and improved hepatobiliary function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005736","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:00:44Z","timestamp":1777608044000},"page":"e1618-e1628","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Treprostinil Minimizes Ischemia-reperfusion Injury of Liver After Circulatory Death Donation\u2014Evidence Using Normothermic Machine Perfusion"],"prefix":"10.1097","volume":"110","author":[{"given":"Yermek","family":"Nigmet","sequence":"first","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shambhavi","family":"Parab","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Pittsburgh, School of Pharmacy, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avantika","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Pittsburgh, School of Pharmacy, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imam H.","family":"Shaik","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Therapeutics, University of Pittsburgh, School of Pharmacy, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmjeet","family":"Randhawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Humar","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Venkataramanan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."},{"name":"Department of Pharmaceutical Sciences, University of Pittsburgh, School of Pharmacy, Pittsburgh, PA."},{"name":"Department of Pathology, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"R1-20260817","first-page":"659","article-title":"Homotransplantation of the liver in humans.","volume":"117","author":"Starzl","year":"1963","journal-title":"Surg Gynecol Obstet"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.ajt.2025.01.022","article-title":"OPTN\/SRTR 2023 annual data report: liver.","volume":"25","author":"Kwong","year":"2025","journal-title":"Am J Transplant"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cld.2016.12.004","article-title":"Extended criteria donors in liver transplantation.","volume":"21","author":"Vodkin","year":"2017","journal-title":"Clin Liver Dis"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/lt.24160","article-title":"Declining liver graft quality threatens the future of liver transplantation in the United States.","volume":"21","author":"Orman","year":"2015","journal-title":"Liver Transpl"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jhep.2023.04.008","article-title":"Donation after circulatory death: novel strategies to improve the liver transplant outcome.","volume":"78","author":"De Carlis","year":"2023","journal-title":"J Hepatol"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/cells8101131","article-title":"Inflammasome-mediated inflammation in liver ischemia-reperfusion injury.","volume":"8","author":"Jim\u00e9nez-Castro","year":"2019","journal-title":"Cells"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrgastro.2012.225","article-title":"Ischaemia-reperfusion injury in liver transplantation\u2014from bench to bedside.","volume":"10","author":"Zhai","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1006\/cryo.1993.1046","article-title":"The effect of a prostaglandin I2 analogue (OP-41483) on energy metabolism in liver preservation and its relation to lipid peroxidative reperfusion injury in rats.","volume":"30","author":"Goto","year":"1993","journal-title":"Cryobiology"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0168-8278(98)80125-6","article-title":"Protective effect of prostaglandin E1 against ischemia\/reperfusion-induced liver injury: results of a prospective, randomized study in cirrhotic patients undergoing subsegmentectomy.","volume":"29","author":"Sugawara","year":"1998","journal-title":"J Hepatol"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.acvd.2016.03.004","article-title":"Pulmonary arterial hypertension: basic knowledge for clinicians.","volume":"109","author":"Santos-Ribeiro","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1165\/ajrcmb.26.2.4695","article-title":"Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery.","volume":"26","author":"Clapp","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pharmthera.2013.10.002","article-title":"Targeted therapies in pulmonary arterial hypertension.","volume":"141","author":"Montani","year":"2014","journal-title":"Pharmacol Ther"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/j.1600-6143.2011.03568.x","article-title":"Treprostinil, a prostacyclin analog, ameliorates ischemia-reperfusion injury in rat orthotopic liver transplantation.","volume":"11","author":"Ghonem","year":"2011","journal-title":"Am J Transplant"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jceh.2012.09.002","article-title":"Treprostinil improves hepatic cytochrome P450 activity during rat liver transplantation.","volume":"2","author":"Ghonem","year":"2012","journal-title":"J Clin Exp Hepatol"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s11095-022-03384-x","article-title":"Treprostinil supplementation ameliorates hepatic ischemia reperfusion injury and regulates expression of hepatic drug transporters: an isolated perfused rat liver (IPRL) study.","volume":"39","author":"Almazroo","year":"2022","journal-title":"Pharm Res"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"e14298","DOI":"10.1111\/ctr.14298","article-title":"An evaluation of the safety and preliminary efficacy of peri- and post-operative treprostinil in preventing ischemia and reperfusion injury in adult orthotopic liver transplant recipients.","volume":"35","author":"Almazroo","year":"2021","journal-title":"Clin Transplant"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/ajt.13708","article-title":"Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (first-in-man) clinical trial.","volume":"16","author":"Ravikumar","year":"2016","journal-title":"Am J Transplant"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41586-018-0047-9","article-title":"A randomized trial of normothermic preservation in liver transplantation.","volume":"557","author":"Nasralla","year":"2018","journal-title":"Nature"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/TP.0000000000001661","article-title":"Normothermic perfusion in the assessment and preservation of declined livers before transplantation: hyperoxia and vasoplegia-important lessons from the first 12 cases.","volume":"101","author":"Watson","year":"2017","journal-title":"Transplantation"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/lt.25000","article-title":"The case for normothermic machine perfusion in liver transplantation.","volume":"24","author":"Ceresa","year":"2018","journal-title":"Liver Transpl"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jhep.2022.04.033","article-title":"Normothermic liver machine perfusion as a dynamic platform for regenerative purposes: what does the future have in store for us?","volume":"77","author":"Lascaris","year":"2022","journal-title":"J Hepatol"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/lt.25439","article-title":"Manipulation of lipid metabolism during normothermic machine perfusion: effect of defatting therapies on donor liver functional recovery.","volume":"25","author":"Boteon","year":"2019","journal-title":"Liver Transpl"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/lt.25383","article-title":"Gene silencing with siRNA (RNA interference): a new therapeutic option during ex vivo machine liver perfusion preservation.","volume":"25","author":"Thijssen","year":"2019","journal-title":"Liver Transpl"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/tri.13780","article-title":"Cell therapy during machine perfusion.","volume":"34","author":"Thompson","year":"2021","journal-title":"Transpl Int"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/jcm7110425","article-title":"Systematic review and meta-analysis on the impact of thrombolytic therapy in liver transplantation following donation after circulatory death.","volume":"7","author":"Jayant","year":"2018","journal-title":"J Clin Med"},{"key":"R27-20260817","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.transproceed.2023.02.003","article-title":"Ultrasound-targeted microbubble cavitation during machine perfusion reduces microvascular thrombi and graft injury in a rat liver model of donation after circulatory death.","volume":"55","author":"Hughes","year":"2023","journal-title":"Transplant Proc"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/ajt.14110","article-title":"Impact of subnormothermic machine perfusion preservation in severely steatotic rat livers: a detailed assessment in an isolated setting.","volume":"17","author":"Okamura","year":"2017","journal-title":"Am J Transplant"},{"key":"R29-20260817","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jhep.2014.02.010","article-title":"Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures.","volume":"60","author":"op den Dries","year":"2014","journal-title":"J Hepatol"},{"key":"R30-20260817","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/tri.13441","article-title":"The future of organ perfusion and re-conditioning.","volume":"32","author":"Weissenbacher","year":"2019","journal-title":"Transpl Int"},{"key":"R31-20260817","doi-asserted-by":"crossref","first-page":"1156845","DOI":"10.3389\/frtra.2023.1156845","article-title":"Current practice and novel approaches in organ preservation.","volume":"2","author":"Ozgur","year":"2023","journal-title":"Front Transplant"},{"key":"R32-20260817","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MOT.0000000000000410","article-title":"Cold storage or normothermic perfusion for liver transplantation: probable application and indications.","volume":"22","author":"Ceresa","year":"2017","journal-title":"Curr Opin Organ Transplant"},{"key":"R33-20260817","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jss.2006.05.009","article-title":"The effect of intraportal prostaglandin E1 on adhesion molecule expression, inflammatory modulator function, and histology in canine hepatic ischemia\/reperfusion injury.","volume":"138","author":"Hafez","year":"2007","journal-title":"J Surg Res"},{"key":"R34-20260817","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/TP.0000000000002021","article-title":"Comparison of BQ123, epoprostenol, and verapamil as vasodilators during normothermic ex vivo liver machine perfusion.","volume":"102","author":"Echeverri","year":"2018","journal-title":"Transplantation"},{"key":"R35-20260817","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jss.2013.04.030","article-title":"A new liver graft preparation method for uncontrolled non-heart-beating donors, combining short oxygenated warm perfusion and prostaglandin E1.","volume":"184","author":"Hara","year":"2013","journal-title":"J Surg Res"},{"key":"R36-20260817","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.transproceed.2016.01.005","article-title":"Adenosine increases hepatic artery flow in liver transplant recipients: a pilot study.","volume":"48","author":"Zhu","year":"2016","journal-title":"Transplant Proc"},{"key":"R37-20260817","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamasurg.2021.6781","article-title":"Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS liver PROTECT randomized clinical trial.","volume":"157","author":"Markmann","year":"2022","journal-title":"JAMA Surg"},{"key":"R38-20260817","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1440-1746.2003.03056.x","article-title":"Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection.","volume":"18","author":"Teoh","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"R39-20260817","doi-asserted-by":"crossref","first-page":"e110642","DOI":"10.1371\/journal.pone.0110642","article-title":"Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion.","volume":"9","author":"Sutton","year":"2014","journal-title":"PLoS One"},{"key":"R40-20260817","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/cryo.2000.2276","article-title":"Bile analysis as a tool for assessing integrity of biliary epithelial cells after cold ischemia\u2014reperfusion of rat livers.","volume":"41","author":"Vajdov\u00e1","year":"2000","journal-title":"Cryobiology"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:00:23Z","timestamp":1786996823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005736","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}